About Reviscon

Reviscon in the Joint Cavity

  • Masks the pain receptors by HA layer it forms.
  • Helps the stimulation of new HA synthesis by the stimulation of synoviocytes and chondrocytes.
  • Because of its filter function; while it is allowing the passage of cells that is needed by cartilage, synovium and synovial fluid; it prevents the infiltration of inflammatory cells.
  • By its shock-absorbing effect, it smooths the force of sudden movement and preserves the joint
  • Because of its barrier function, it prevents the destructive molecules such as proteases, pro-inflammatory cytokines and free oxygen radicals to reach cartilage and synovium
  • Contributes the preservation and construction of joint cartilage and synovial membrane.

High Molecular Weight NaHA Line

Reviscon, Reviscon Plus and Reviscon Mono

  • Reviscon, Reviscon Plus, and Reviscon Mono are intra-articular injections that contains hyaluronic acid solution.
  • They are prefilled syringes for single use for intra-articular injection.
  • Reviscon contains 1% hyaluronic acid (20 mg/2 ml).
  • Reviscon Plus contains 1.6% hyaluronic acid (32 mg/2 ml).
  • Reviscon Mono contains 2.0% hyaluronic acid (48 mg/2.4 ml).

Indication of Reviscon

It is used in the treatment of pain and loss of flexibility as a result of degenerative and traumatic changes in any synovial joint (flexible joints; such as knees, hips, shoulders, elbows, finger and toes).

It is indicated in the cases that had inadequate response to non-pharmacological conservative therapy and simple analgesics.Treatment can be applied to more than one joint at the same time. Therapy course may be repeated when needed.

Click here to download the brochure